Copper Peptides (GHK-Cu and AHK-Cu): What They Do and What the Evidence Shows

Copper peptides are short peptides bound to a copper ion; the best known is GHK-Cu (glycyl-L-histidyl-L-lysine copper), a tripeptide found naturally in human blood, at levels that fall with age. It is a common skin-care ingredient, listed as “copper tripeptide-1”. AHK-Cu is a related copper peptide studied mainly for hair. The human evidence is smaller than the marketing suggests: a handful of small trials of gels and creams, with mixed results, and no human trials of injected GHK-Cu at all.

This guide covers both compounds: what they are, how they work, what the trials found, how they are used, and the safety picture. It also merges our older GHK-Cu guide.

What the human trials show

A 2026 systematic review notes that most human data are small facial-cream studies. Several often-quoted skin results below (for example, more collagen in 70% of participants) come from small studies whose full data we could not check; treat them as preliminary.

What Are Copper Peptides?

Copper peptides are small complexes made up of a short chain of amino acids bonded to a copper ion. The two most studied in the research and biohacking space are GHK-Cu (glycyl-L-histidyl-L-lysine copper) and AHK-Cu (alanyl-histidyl-lysine copper). Both are tripeptides, meaning they are made of exactly three amino acids, and both have a high affinity for copper(II) ions.

GHK-Cu was first isolated from human plasma albumin in 1973 by researcher Loren Pickart, who noticed that older liver tissue began functioning like younger tissue when incubated with blood from younger subjects. The active factor turned out to be a small tripeptide. From that discovery, decades of research followed, covering wound healing, skin regeneration, hair growth, antioxidant activity, and eventually gene expression analysis showing GHK-Cu’s influence over thousands of human genes.

AHK-Cu came to attention later and shares structural similarities with GHK-Cu but differs in its amino acid sequence. The substitution of alanine for glycine gives AHK-Cu greater chemical stability, which matters significantly for topical formulations and long-term storage. In research contexts, AHK-Cu has been studied most intensively in the context of hair follicle biology.

GHK itself is natural, although the products sold are lab-made. GHK naturally occurs in human plasma, saliva, and urine. The complex with copper forms readily in biological conditions and plays a role in the body’s normal tissue remodeling response. That natural origin is part of why topical use is generally considered low-risk, but it says nothing about injecting large amounts.

How Do Copper Peptides Work?

For a long time, the working assumption was that GHK-Cu’s effects were primarily driven by its ability to carry and deliver copper ions into cells, where copper acts as a cofactor in a range of enzymatic processes. That explanation still holds some validity, but since 2010 a more sophisticated picture has emerged.

Using the Broad Institute’s Connectivity Map, a library of transcriptional responses to known biological perturbagens, researchers discovered that GHK-Cu influences the expression of a substantial number of human genes.

It appears to reset gene activity patterns toward a younger, more regenerative state: upregulating genes associated with tissue repair, collagen production, and antioxidant defense, while downregulating genes associated with inflammation, tissue destruction, and cellular aging.

The practical consequences of this are significant. At the cellular level, GHK-Cu stimulates both the synthesis and the regulated breakdown of collagen and glycosaminoglycans, supports fibroblast activity, attracts immune and endothelial cells to sites of injury, and promotes angiogenesis (the formation of new blood vessels).

It also activates the production of metalloproteinases, the enzymes that break down damaged dermal proteins, alongside their inhibitors, suggesting a role in intelligent tissue remodeling rather than simple stimulation.

AHK-Cu operates through a partially overlapping mechanism. It stimulates fibroblast proliferation, elevates vascular endothelial growth factor (VEGF) production, and suppresses transforming growth factor-beta1, a cytokine involved in fibrosis and hair follicle regression.

In dermal papilla cells, which are specialized fibroblasts central to the hair growth cycle, AHK-Cu has been shown to promote proliferation and reduce programmed cell death. Researchers have also proposed that AHK-Cu may inhibit the conversion of testosterone to DHT and block DHT’s activity at follicle receptors, though this specific mechanism requires more investigation.

Both compounds are absorbed through the stratum corneum when applied topically, with copper peptide complexes shown in research to penetrate this outer skin barrier in quantities sufficient to trigger regenerative activity in the dermis below.

Liposomal and microemulsion delivery systems have been shown to improve skin penetration by as much as three times compared to standard formulations.

GHK-Cu benefits: what the research shows

Below are the areas most often cited, with the type of evidence behind each. Human trial results are in the table above; most of the rest is cell or animal research.

Skin regeneration and anti-ageing (small human studies)

Multiple clinical studies have evaluated GHK-Cu’s effects on aging skin. In one well-cited trial, a GHK-Cu cream applied to the thigh skin for 12 weeks improved collagen production in 70% of participants, compared to 50% for a vitamin C cream and 40% for retinoic acid.

A separate study found that twice-daily application for 12 weeks improved skin laxity, clarity, firmness, and appearance, reduced fine lines and coarse wrinkles, decreased mottled pigmentation, and increased skin density and thickness. It also strongly stimulated keratinocyte proliferation in the dermis.

An independent pilot study by Kruger et al. confirmed increases in epidermal and dermal thickness, improved skin hydration, significant smoothing of the skin, increased elasticity, and elevated production of collagen I.

Wound healing (animal studies plus two human ulcer trials)

In humans, a GHK-Cu gel improved diabetic foot ulcer closure, but a cream did not help venous leg ulcers. In animal models, topical GHK-Cu resulted in wound size reduction of 64.5% over 13 days, compared to 28.2% in untreated controls.

The mechanism involves accelerated wound contraction, improved collagen deposition, angiogenesis stimulation, and anti-inflammatory activity. Notably, GHK-Cu injected in one area of the body has been shown to improve healing at distant body areas in rats, mice, and pigs, suggesting a systemic signaling component beyond simple local effects.

Hair growth

In hair loss research, GHK-Cu has been studied both as a topical treatment and in combination with other compounds. Topical solutions with concentrations of 50 to 100 mg/mL, applied once daily for 6 months in combination with 5-aminolevulinic acid, produced significant improvements in hair growth in clinical protocols.

The mechanism is primarily through follicle-level angiogenesis and the stimulation of the anagen phase, the active growth stage of the hair cycle. One 2024 microemulsion study found that a GHK-Cu delivery system produced earlier entry into the anagen phase than 5% minoxidil in animal models, with hyperpigmentation and visible hair regrowth appearing as early as 6 days.

Antioxidant and anti-inflammatory activity (lab studies)

GHK-Cu has been shown to quench hydroxyl and peroxyl radicals more effectively than glutathione in laboratory assays, making it a potent endogenous antioxidant. In cell culture studies, pretreatment with GHK-Cu significantly reduced reactive oxygen species (ROS) levels induced by hydrogen peroxide.

Its anti-inflammatory effects have been documented through reductions in TNF-alpha and IL-6, two key pro-inflammatory cytokines, via suppression of the NF-kB and p38 MAPK signaling pathways. These findings have prompted research into its potential relevance for pulmonary fibrosis and COPD.

Cognitive and neurological research (mouse studies)

More recent research has explored GHK-Cu’s effects on neurological function. In aged mice (28 months old) treated with GHK at 10 mg/kg five times per week for three weeks, preliminary observations suggested partial reversal of cognitive impairment through anti-inflammatory and epigenetic pathways.

GHK is absorbed efficiently across the blood-brain barrier in rodent and primate models, which is what makes this application theoretically plausible. This research is early and should be interpreted cautiously, but it adds to the picture of a compound with unusually broad biological activity.

AHK-Cu Benefits: Where It Stands Out

AHK-Cu has a narrower but well-focused research profile. Its standout application is hair follicle biology, where it has produced some of the more compelling data in the copper peptide space.

Hair Follicle Stimulation

A 2007 study published in Archives of Pharmacal Research evaluated AHK-Cu’s effects on human hair growth ex vivo and on cultured dermal papilla cells.

At concentrations of 10 picomolar to 1 nanomolar, AHK-Cu significantly stimulated the elongation of human hair follicles and promoted dermal papilla cell proliferation.

At 1 nanomolar, it also reduced apoptosis (programmed cell death) in dermal papilla cells, with elevated Bcl-2/Bax ratios and reduced caspase-3 and PARP activity serving as the cellular markers.

The researchers concluded that AHK-Cu promotes hair follicle growth through a combination of stimulating proliferation and preventing follicle cell death.

Anagen Phase Extension

AHK-Cu research suggests the compound may extend the anagen phase of the hair growth cycle, keeping follicles in their active growth state for longer. This mechanism is particularly valuable for people experiencing progressive hair miniaturization, where the growth phase shortens with each successive cycle.

By prolonging anagen, AHK-Cu theoretically allows follicles to produce longer, thicker hair shafts before transitioning to the resting phase.

Scalp Circulation and VEGF Stimulation

AHK-Cu has been shown to stimulate VEGF production in fibroblasts, promoting angiogenesis in the scalp. Better vascular supply to hair follicles directly supports follicle activity, since follicles undergo rapid cell turnover and are highly dependent on blood-delivered oxygen and nutrients.

This mechanism complements its direct effects on follicle cell biology and may explain some of the density improvements observed in user reports.

Skin and Collagen Benefits

Although hair is AHK-Cu’s primary research focus, it shares the copper peptide class’s broader collagen and elastin stimulating properties.

Research suggests AHK-Cu may stimulate Type 1 collagen production and supports fibroblast proliferation in the dermal matrix. For this reason it appears in both hair care and anti-aging skincare formulations, often at concentrations of 5 to 10%.

GHK-Cu vs AHK-Cu: Which One Should You Use?

This is the most common question when people encounter both compounds for the first time. The honest answer is that they are complementary rather than competitive.

GHK-Cu is the more extensively researched compound with the broader application profile. If your primary interest is skin regeneration, wound healing, antioxidant activity, or general anti-aging use, GHK-Cu is the better-documented choice. Its research spans multiple tissue types and biological systems, and its gene expression data is more comprehensive.

AHK-Cu has superior chemical stability, which matters practically for topical formulations and shelf life. Its research focus on dermal papilla cells and hair follicle biology gives it a more targeted profile for hair loss applications.

If hair retention and regrowth are the primary goals, AHK-Cu’s mechanism is more specifically aligned with that objective, and its stability advantage means more of the active compound survives in the product and on the skin.

Many formulations in both research and commercial contexts combine both at different concentrations, using GHK-Cu for its broader regenerative activity and AHK-Cu for follicle-specific stimulation.

If budget allows, a combined approach is a reasonable starting point. If choosing between them for a hair-focused protocol specifically, AHK-Cu’s stability and directly relevant research give it an edge in that application.

How copper peptides are used

Because copper peptides are used in multiple formats, from topical serums and creams to injectable solutions, the dosage conversation is more nuanced than for most compounds. There is no universally standardized protocol, and the ranges below describe how products are formulated and what studies used, not personal doses.

Topical Serums and Creams (GHK-Cu)

Topical GHK-Cu products are typically formulated at concentrations between 2% and 10%. For general anti-aging skin use, 4% is a commonly cited effective concentration for once or twice daily application to the face, neck, and scalp.

For hair growth protocols, research has used solutions at 50 to 100 mg/mL (5% to 10%) applied once daily. If using an advanced cream with high mg content, a dollop approximately equivalent to 50 mg is a reasonable starting point.

Application should be to clean, dry skin and can be followed by other serums, though acids, retinoids, and vitamin C should be applied at a separate time to avoid potential interactions.

Topical Formulations (AHK-Cu)

AHK-Cu is most commonly used in hair care formulations at concentrations of 5% to 30% depending on the delivery system. Liposomal versions, which encapsulate the peptide in lipid layers for better cellular delivery, are generally used at lower concentrations (7% to 10%) because of their substantially improved absorption.

Standard topical AHK-Cu is typically applied once daily to affected scalp areas and massaged in gently. Consistent daily application over a minimum of three to six months is needed to assess results meaningfully.

Injectable GHK-Cu

Injectable GHK-Cu is sold as freeze-dried powder for research. It has never been tested in a human trial, and we found no published human pharmacokinetic data, so its half-life and a safe dose are unknown. The FDA lists injectable GHK-Cu as “nominated but withdrawn” from its Category 2 safety-risk list, citing possible immune reactions from aggregation and impurities and limited human data. We do not give injection protocols.

Oral / Capsule Forms

Standard oral capsules of GHK-Cu are generally considered ineffective because the peptide is broken down in the gastrointestinal tract before reaching systemic circulation.

Liposomal encapsulated oral formulations at doses of 10 mg per day or more have shown some evidence of efficacy in research, as the lipid encapsulation protects the peptide through digestion. This method remains a less validated delivery route compared to topical and injectable forms.

Using copper peptide skin care

Copper peptides are commonly employed by those who desire to use skincare products to improve their skin’s condition. They can also be used to treat serious skin and hair problems. Copper peptides can be found in serums and moisturizers for the face. However, peptide-based cleansers should not be used because any effects will be washed away after use.

Copper peptides are found in the most concentrated form in serum. Apply a few drops of the serum to your scalp to promote hair growth. With your fingertips, gently massage it in. It is not necessary to rinse it.

Apply your copper peptides serum to your skin in the following order for skin concerns: cleanser, toner, copper peptides serum, sunscreen (in the morning), cream, or moisturizing lotion (in the morning or afternoon, or evening), and face moisturizer.

Copper peptides are also found in several face moisturizers. Choose a cream for dry skin and a lotion for normal to oily skin for the greatest results. Use soft upward strokes twice a day, in the morning and at night.

Side effects and safety

The topical safety profile of copper peptides is generally considered favorable based on the available research. Topical skin irritation is the most commonly reported side effect and is usually linked to the formulation carrier rather than the peptide itself.

One phenomenon worth being aware of is sometimes referred to as ‘copper uglies’ in user communities. This describes a temporary appearance of accelerated skin aging or roughness in some users, potentially related to GHK-Cu’s dual role in stimulating both collagen synthesis and metalloproteinases (the enzymes that break down damaged collagen).

The prevailing interpretation is that this reflects an initial phase of collagen remodeling rather than permanent damage, and it typically resolves with continued use or temporary discontinuation. However, human data on this specifically is limited to anecdotal reports.

For injectable copper peptides, the risks are more significant. Infection, allergic reactions, and improper dosing are all real concerns with self-administered injectables, and these risks apply regardless of how well-characterized a compound’s preclinical safety profile is. Clinical supervision is strongly recommended for this route of administration.

There is no significant long-term human safety data for either GHK-Cu or AHK-Cu in injectable or high-dose oral contexts. The favorable safety signals from topical use do not automatically transfer to systemic routes.

Anyone using copper peptides beyond topical application should approach such use with appropriate caution and ideally with professional oversight.

Stop any copper peptide product that causes redness, hives, itching or burning, and patch-test new products on the inside of the elbow for 24 hours first. The FDA’s concerns about immune reactions apply to injectable forms.

Legal status and sport

GHK-Cu is not an approved drug anywhere we could find. In the EU it is listed as a cosmetic ingredient (copper tripeptide-1, skin conditioning). In the US, injectable GHK-Cu was nominated for pharmacy compounding and then withdrawn from the FDA’s Category 2 list. WADA has not named GHK-Cu, but its S0 section bans unapproved pharmacological substances, and its 2027 notes say unnamed peptides may still be prohibited; athletes should check with their anti-doping organization before using injectable products.

What Results Should You Realistically Expect?

Copper peptides reward patience. These are not compounds that produce overnight changes. Their mechanism involves influencing cellular behavior and gene expression over time, which means the timeline for visible results is longer than many people expect.

For skin applications, most clinical studies ran for 12 weeks before assessing outcomes, and the improvements observed were gradual and cumulative. You should not expect dramatic changes in the first two to four weeks.

What tends to emerge over three to six months of consistent use is improved skin texture, reduced fine lines, better hydration, and in some cases measurable increases in skin thickness and firmness.

For hair applications, reduced shedding is often the first sign of activity, typically appearing within the first four to eight weeks for people who respond. Visible density improvements and hair thickening generally take three to six months.

Regrowth in areas of established loss is less predictable and more dependent on follicle health at baseline. Copper peptides are most effective as a protective and maintenance strategy, and least predictable as a regrowth treatment for advanced loss.

Both compounds work best as part of a broader approach. For skin, that means a solid foundational skincare routine. For hair, that means addressing the underlying cause of loss alongside using copper peptides as a supportive tool.

Neither GHK-Cu nor AHK-Cu replaces a comprehensive protocol, but for people already doing the fundamentals, they add a well-researched layer of support.

Where to buy copper peptides

For skin care, copper tripeptide-1 is sold in many serums and creams. For research-grade GHK-Cu powder, Sarmguide’s pick is SwissChems, which publishes independent test results per batch. Check the certificate of analysis for identity and purity; see our lab tests guide.

Conclusion

GHK-Cu is a natural copper peptide with a long research history, most of it in cells and animals. In people, the evidence is a few small trials: a gel helped diabetic foot ulcers, a cream did not help leg ulcers, and skin-care results were mixed. AHK-Cu has interesting hair-follicle lab data but no human trials. Topical use is generally considered low-risk; injected GHK-Cu has never been tested in humans. Related: peptides for hair growth · peptides for skin tightening · GHK-Cu vs BPC-157